Blog Media Careers International Patients Eye Test
Request A Call Back
Investing
  • For Investors – Dr. Agarwal’s Eye Hospital Ltd

For Investors – Dr. Agarwal’s Eye Hospital Ltd

Shareholding Pattern June 30, 2024
Shareholding Pattern March 31, 2024
Shareholding Pattern December 31, 2023
Shareholding Pattern September 30, 2023
Shareholding Pattern June 30, 2023
Shareholding Pattern March 31, 2023
Shareholding Pattern December 31, 2022
Shareholding Pattern - September 30, 2022
Shareholding Pattern - June 30, 2022
Shareholding Pattern - March 31, 2022
Shareholding Pattern - December 31, 2021
Shareholding Pattern - September 30, 2021
Shareholding Pattern - June 30, 2021
Shareholding Pattern - March 31, 2021
Shareholding Pattern - December 31, 2020
Shareholding Pattern - June 30, 2020
Shareholding Pattern - September 30, 2020
Shareholding Pattern - December 31, 2019
Shareholding Pattern - June 30, 2019
Shareholding Pattern - March 31, 2020
Shareholding Pattern - September 30, 2019
Shareholding Pattern - September 30, 2018
Shareholding Pattern - December 31, 2018
Shareholding Pattern - June 30, 2018
Shareholding Pattern - March 31, 2019
Shareholding Pattern - December 31, 2017
Shareholding Pattern - June 30, 2017
Shareholding Pattern - September 30, 2017
Shareholding Pattern - March 31, 2018
Shareholding Pattern - December 31, 2016
Shareholding Pattern - June 30, 2016
Shareholding Pattern - March 31, 2017
Shareholding Pattern - September 30, 2016
Shareholding Pattern - March 31, 2016
Shareholding Pattern - December 31, 2015
Shareholding Pattern - June 30, 2015
Shareholding Pattern - September 30, 2015
Corporate Governance Report June 30, 2024
Corporate Governance Report March 31, 2024 (2)
Corporate Governance Report December 31, 2023
Corporate Governance Report September 30, 2023
Corporate Governance Report June 30, 2023
Corporate Governance Report March 31, 2023
Corporate Governance Report December 31, 2022
Corporate Governance Report September 30, 2022
Corporate Governance Report June 30, 2022
Corporate Governance Report March 31, 2022
Corporate Governance Report December 31, 2021
Corporate Governance Report September 30, 2021
Corporate Governance Report June 30, 2021
Corporate Governance Report March 31, 2021
Corporate Governance Report- December 31, 2020
Corporate Governance Report -June 30, 2020
Corporate Governance Report -September 30, 2020
Corporate Governance Report -December 31, 2019
Corporate Governance Report- June 30, 2019
Corporate Governance Report -March 31, 2020
Corporate Governance Report September 30, 2019
Coporate Governance Report- December 31, 2018
Corporate Governance Report- June 30, 2018
Corporate Governance Report- March 31, 2019
Corporate Governance Report- September 30, 2018
Corporate Governance Report- December 31, 2017
Corporate Governance Report- June 30, 2017
Corporate Governance Report- March 31, 2018
Corporate Governance Report- September 30, 2017
Corporate Governance Report- Non Applicability - December 31, 2016
Corporate Governance Report- Non Applicability - September 30, 2016
Corporate Governance Report- Non Applicability- June 30, 2016
Corporate Governance Report-Non Applicability - March 31, 2016
Corporate Governance Report - Non-Applicability- September 30 2015
Corporate Governance Report- Non Applicability - March 31, 2016
Corporate Governance Report- Non- Applicability- December 31 2015
Regulation 31(1) - SAST Declaration
NDU Regulation 31(1) read with Reg-28(3) - 20.11.2019
Regulation 31(1) read with Regulation 28(3) of SEBI SAST-Regulation-2011- 04.10.2019
Regulation-31(2)-Release of Pledge - 20.11.2019
SAST DISCLOSURE AHCL TO BSE - 14-15
SAST DISCLOSURE AHCL TO BSE - 15-16
Regulation 74(5) - 30.06.2024
Reconciliation of Share Capital Audit June 30, 2024
Investor Complaints- 30.06.2024
Regulation 74(5) - 31.03.2024
Investor Complaints- 31.03.2024
Regulation 7(3) - 31.03.2024
Regulation 74(5) - 31.12.2023
Reconciliation of Share Capital Audit Report December 31, 2023
Regulation 74(5) - 30.09.2023
Reconciliation of Share Capital Audit Report September 30, 2023
Investor Complaints- 31.12.2023
Investor Complaints- 30.09.2023
Regulation 74(5) - 30.06.2023
Investor Complaints- 30.06.2023
Reconciliation of Share Capital Audit Report June 30, 2023
Regulation 7(3) - 31.03.2023
Regulation 74(5) - 31.03.2023
Regulation 40(9) - 31.03.2023
Investor Complaints- 31.03.2023
Reconciliation of Share Capital Audit Report March 31, 2023
Regulation 74(5) - 31.12.2022
Reconciliation of share capital audit December- 31.12.2022
Investor Complaints- 31.12.2022
Regulation 74(5) - 30.09.2022
Reconciliation of Share Capital Audit Report September 30, 2022
Investor Complaints - 30.09.2022
Investor Complaints - 30.06.2022
Reconciliation of Share Capital Audit Report June 30, 2022
AEHL IEPF Advertisement Final
Regulation 74(5) - 30.06.2022
Regulation 74(5) - 31.03.2022
Reconciliation of Share Capital Audit Report March 31, 2022
Regulation 7(3) - 31.03.2022
Investor Complaints 31.03.2022
Regulation 39(3)- Loss of Share Certificate
Regulation 74(5)- 31.12.2021
Regulation 39(3) - Loss of Share Certificate
Outcome of the Board Meeting- 23.07.2021
Investor Complaint 30.06.2021
Notice to Shareholders for transfer of Equity shares to IEPF
Regulation 74(5)- 30.06.2021
Closing of Trading Window 31.06.2021
Reconciliation of Share Capital Audit 31.03.2021
Annual Secretarial Compliance Report 31.03.2021
Outcome of the Board Meeting - 04-05-2021
Regulation 40(9)- Oct 1, 2020- March 31,2021
Regulation 7(3)- 31.03.2021
Regulation 74(5)- 31.03.2021
Non- Applicability- Large Corporate Entities
Announcement under Regulation 30 - Cessation of SMP
Board Meeting Intimation - 25.07.2023
Trading Window Closure - 30.06.2024
Trading Window Closure - 31.03.2024
Announcement under Regulation 30-27.03.2024
Announcement under Regulation 30-22.03.2024
Announcement under Regulation 30-20.03.2024
Announcement under Regulation 30-01.03.2024
Announcement under Regulation 30-08.02.2024
Appointment of Secretarial Auditor 2023-2024
Announcement under Regulation 30
Trading Window Closure - 31.12.2023
Revision of Record Date - 31.10.2023
Board Meeting Intimation - 20.10.2023
Trading Window Closure - 30.09.2023
Board Meeting Intimation - 04.08.2023
Notice of Advertisement for Transfer of Shares to IEPF
Trading Window Closure - 30.06.2023
Board Meeting Intimation - 06.05.2023
Newspaper Publication Financial Results- 31.03.2023
Board Meeting Outcome-31.03.2023
Annual Secretarial Compliance- 31.03.2023
Related Party Transaction Report 31.03.2023
Trading Window Closure - 31.03.2023
Board Meeting Intimation - 21.01.2023
Trading Window Closure - 31.12.2022
Board Meeting Reschedule Intimation - 30.09.2022
Board Meeting Intimation - 30.09.2022
Related Party Transaction Report 30.09.2022
Trading Window Closure - 30.09.2022
Board Meeting Intimation- 30.06.2022
Trading Window Closure - 30.06.2022
Annual Secretarial Compliance- 31.03.2022
Related Party Transaction Report 31.03.2022
Board Meeting Outcome-31.03.2022
Board Meeting intimation-31.12.2021
Related Party Transaction - 30.09.2021
AEHL TW Closure 31.03.2022
Change in Directorate 28-03-2022
Closure of Trading Window
Announcement of Appointment of CS
Announcement under Regulation 30(5)
Board Meeting Intimation 29.10.2021
Board Meeting Intimation 23.07.2021
Details of shareholder whose dividend remain unpaid for consecutive 7 years 2013-14 to 2018-19
Board Meeting Intimation - 04.05.2021
Related Party Transaction 31.03.2021
Board Meeting Intimation - 25.01.2021
Board Meeting Intimation - 30.10.2020
Board Meeting Intimation-12.8.2020
Notice to Shareholders in respect of transfer of Equity Shares to IEPF
Board Meeting Intimation - 28.01.2020
Board Meeting Intimation 13.05.2019
Board meeting Intimation-05.08.2019
Board meeting Intimation-25.10.2019
Board Meeting Intimation - 08.02.2019
Board Meeting Intimation - 13.05.2019
Board Meeting Intimation - 13.11.2018
Board Meeting Intimation-14.08.2018
Board Meeting Intimation - 02.02.2018
Board Meeting Intimation - 17.08.2017
Board Meeting Intimation - 22.11.2017
Board Meeting Intimation - 28.05.2018
Notice of Advertisement Unclaimed Dividend
Board Meeting Intimation 01.08.2016
Board Meeting Intimation 23.05.2017
Board Meeting Intimation 26.10.2016
Board Meeting Intimation-28.01.2017
Board meeting Intimation 04.02.2016
Board meeting Intimation 19.05.2016
Postal Ballot Advertisement dated 02-11-2024
Notice of Postal Ballot dated 29-10-2024

List of Directors

S. No.

DIN

Name

Father Name/Husband Name

Designation

1

00435684

Dr Amar Agarwal

Dr. Jaiveer Agarwal

Chairman cum Managing Director

2

01365659

Dr. Athiya Agarwal

Dr. Amar Agarwal

Whole-time Director

3

01074272

Dr. Adil Agarwal

Dr. Amar Agarwal

Director

4

00040199

Mr. Shiv Agrawal

Dr. Bishwanath Prasad Agrawal

Independent Director

5

02825465

Mr. Balakrishnan Venkatraman

Mr. Venkatraman

Independent Director

6

07099052

Ms. Latha Ramanathan

Mr. Ramanathan Ramachandran

Independent Director

 

Audit Committee Details

Sr

DIN Number

Name of Committee members

Category 1 of directors

Category 2 of directors

Date of Appointment

1

00435684

Dr. Amar Agarwal

Executive Director

Member

06-02-2019

2

07099052

Ms. Latha Ramanathan

Non-Executive – Independent Director

Member

25-07-2024

3

02825465

Mr. Balakrishnan Venkatraman

Non-Executive – Independent Director

Member

25-07-2024

 

Nomination and remuneration Committee Details

Sr

DIN Number

Name of Committee members

Category 1 of directors

Category 2 of directors

Date of Appointment

1

01074272

Dr. Adil Agarwal

Non-Executive – Non Independent Director

Member

03-06-2019

2

07099052

Ms. Latha Ramanathan

Non-Executive – Independent Director

Member

25-07-2024


Stakeholders Relationship Committee Details

Sr

DIN Number

Name of Committee members

Category 1 of directors

Category 2 of directors

Date of Appointment

1

00435684

Dr. Amar Agarwal

Executive Director

Member

06-02-2019

2

07099052

Ms. Latha Ramanathan

Non-Executive – Independent Director

Member

25-07-2024

3

02825465

Mr. Balakrishnan Venkatraman

Non-Executive – Independent Director

Member

25-07-2024


Corporate Social Responsibility Committee Details

Sr

DIN Number

Name of Committee members

Category 1 of directors

Category 2 of directors

Date of Appointment

1

01365659

Dr. Athiya Agarwal

Executive Director

Chairperson

05-08-2019

2

00435684

Dr. Amar Agarwal

Executive Director

Member

05-08-2019

3

07099052

Ms. Latha Ramanathan

Non-Executive – Independent Director

Member

25-07-2024

 

Cessation of Mr. Sanjay Anand Independent Director
Appointment of Mr. Shiv Agrawal as Independent Director
Cessation of Mrs. Lakshmi Subramanian Independent Director
Appointment of Ms. Latha Ramanathan as Independent Director
Familiarisation Program Imparted to Independent Directors- 31.03.2024
Familiarisation Program Imparted to Independent Directors- 31.03.2023
Familiarisation Program Imparted to Independent Directors- 31.03.2022
Appointment of Mr. KV Bala as Independent Director
Resignation of Mr. TR Ramasubramanian
Terms and conditions of Appointment of Independent Directors
Announcement of Appointment of CS
Resignation of Company Secretary- 23.07.2021
Familisation program for Independent Directors
Appointment Letter of Mr. T R Ramasubramanian & Ms. Lakshmi Subaramanian
Appointment of Chief Financial Officer Mr. Udhay Shankar Davey 07.12.2020
Appointment of Independent Director & Company Secretary- 03.06.2019
Change in Directors- Dr. Adil & Anosh- 02.05.2016
Composition of Board of Directors
Contact Details of the Authorised Key Managerial Personnel under Regulation 30 (5) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015-22.11.2017
Designation of Chief Financial Officer as Compliance Officer of the Company- 31.05.2017
Designation of Director as Compliance Officer of the Company- 29.12.2018
Designation of Director as Compliance Officer of the Company-01.01.2019
Familiarisation Program Imparted to Independent Directors
Familiarization Programme for Independent Directors
Letter of Appointment to Independent Director (9th Sep 2014)
Letter of Appointment to Independent Director (10th Sep 2015)
Material Event - Contact Details of Authorised Key Managerial Personnel under Regulation 30(5) of SEBI (LODR), Regulations, 2015- 28.05.2018
Material Event-Contact Details of Authorised Key Managerial Personnel under Regulation 30(5) of SEBI (LODR), Regulation 2015- 05.08.2019
Notice of Candidature- Mr. M.R.G Apparao- 11.05.2015
Notice of Candidature- Mr. Sanjay Anand-01.07.2014
Notices of Resignation- Mr. Prabhat Toshniwal- 28.03.2015
R Sabesan CFO Designation Change-01.06.2017
Appointment Letter- Mr. Sanjay Anand- 09.09.2014
Reconstitution of Nomination and Remuneration committee 03.06.2019
Regulation 30 of SEBI (LODR) Regulations, 2015 - Change in CFO- 28.05.2018
Regulation 30 of SEBI LODR - Change in Company Secretary & Compliance Officer- 22.11.2017
Regulation 30(5) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015-Reg
Resignation of Chief Financial Officer Ms. Saradha Govindarajan- 14.07.2020
Resignation of Company Secretary- 29.12.2018
Resignation of Director and Designation of Chief Financial Officer as Compliance Officer of The Company- 30.04.2019
Resignation of Independent Director- Mr. M R G Appa Rao- 31.01.2019
Resignation of Non Executive Directors - 28.09.2017
List of Notices for Unclaimed Dividend for the year 2015-16- Transfer of Shares under sub-section 6 of Section 124 of Companies Act, 2013 to IEPF
Details of Unpaid Dividend 31.03.2022
List of unclaimed Shares liable to be transfered to IEPF if not claimed by respective shareholders
ODR Portal

Investor Service Requests – Physical Shares
In relation to issue of securities mandatorily in dematerialized form and as an ongoing measure to enhance ease of dealing in securities markets by investors, SEBI vide Circular SEBI/HO/MIRSD/MIRSD/RTAMB/P/CIR/2021/655 dated 3rd November 2021, read with Circular dated 14th December 2021 and SEBI/HO/MIRSD/MIRSD_RTAMB/P/CIR/2022/8 dated 25th January 2022 has prescribed common and simplified norms for processing various investor’s service requests. Forms for such requests have also been prescribed and the same is enclosed for reference of the shareholders.

  1. Request for relating to the update of PAN, KYC details, Nomination, etc. shall be made in Form ISR-1
  2. Request for change in specimen signature shall be in Form ISR-2 duly attested.
  3. Request by all eligible physical holders shall register Nomination in Form SH-13 or Declaration to Optout in Form ISR-3
  4. In case of changes to or cancellation of Nomination made earlier it shall be in Form SH-14
  5. If the below information is not furnished, folios containing incomplete details as on 01-04-2023 would be frozen:
    a. Valid PAN including that of joint shareholders duly linked with Aadhaar
    b. Nomination (If shares are held in single name)
    c. Postal Address with Pin code, Email id and Mobile Number
    d. Bank Account details (Bank Name, Branch, Bank Account No, IFSC Code and MICR code)
    e. Specimen Signature
  6. No service requests would be processed in respect of such frozen folios unless and until the specified information have been furnished. Also, payment of dividend would be only through electronic mode for which intimation would be furnished.
  7. Frozen folios would be reverted to normal status by RTA only upon the prescribed information have been furnished or the entire shares under the folio dematerialized.
  8. If such folios continue to remain frozen as on 31st December 2025, the same would be referred to concerned authorities under the provisions of Benami Transactions (Prohibition) Act, 1988/Prevention of Money Laundering Act, 2002.
  9. In case PAN has not been linked to Aadhaar as on 31-03-2022 or extended date if any, specified by the Income Tax Authorities the related folios shall also be frozen.
  10. Request for issue of Duplicate Certificate and other Service Requests including transmission, transposition etc., shall be made in Form ISR-4
  11. For any clarification, please get in touch with our RTA:
    Integrated Registry Management Services Pvt Ltd.,
    Attn: Ms. Anusha

    ‘Kences Towers’ 2nd Floor, No. 1, Ramakrishna Street
    North Usman Road, T.Nagar, Chennai – 600 017.
    Phone No: 044 – 28140801 | 28140803; Fax: 044 – 28142479
    E-mail: corpserv@iepindia.com
Details of Unpaid Dividend 31.03.2022
Credit Rating 2024-2025
Credit Rating 2023-2024
Credit Rating 2023
Credit Rating- 2022
Reaffirmation of Credit Rating - 2021
Credit Rating BSE Intimation
Reaffirmation of Credit Rating
Policy on Materiality of Related Party Transaction
Corporate Social Responsibility (CSR) Policy
Insider Trading Policy
Nomination and Remuneration Policy
Policy-on-Disclosure-of-Material-Event-Information
POLICY ON PRESERVATION OF DOCUMENTS
SEXUAL HARASSEMENT PREVENETION POLICY
VIGIL MECHANISM WHISTLE BLOWER POLICY
RISK MANAGEMENT POLICY
Code for Fair Disclosure
Code of Conduct for Board Members and Senior Management Personnel
Code of Conduct for Prohibition of Insider Trading
Regulation 8(1) of SEBI (Prohibition of Insider Trading) Regulations, 2015
CSR Projects 2023-24
CSR Projects 2022-23
CSR Projects 2021-22
CSR Projects 2020-21

Financial Reports

Quarterly Reports

Q1 - Unaudited Financial Results 30-06-2024

Annual Report

Dr. Agarwal's Voting Results Scrutinizers Report 2024
Dr. Agarwal's 30th AGM Proceedings 2024
Annual Report 2023-24
30th AGM Notice

Quarterly Reports

Q1 - Unaudited Financial Results 30-06-2023
Q2 - Unaudited Financial Results 30-09-2023
Q3 - Unaudited Financial Results 31-12-2023
Q4 - Audited Financial Results 31-03-2024

Annual Report

MGT-7 Annual Return 2022-23
Dr. Agarwal's Voting Results Scrutinizers Report
Dr. Agarwal's 29th AGM Proceedings 2023
Annual Report 2022-23
29th AGM Notice

Quarterly Reports

Q1 - Unaudited Finanical Results 30-06-2022
Q2 - Unaudited Finanical Results 30-09-2022
Q3 - Unaudited Finanical Results 31-12-2022
Q4 - Audited Financial Results 31-03-2023

Annual Report

Annual Report 2021-22
28th AGM Notice
Dr. Agarwal's Voting Results Scrutinizers Report
Dr. Agarwal's 28th AGM Proceedings 2022
Dr. Agarwal's AGM Book Closure
MGT-7 Annual Return 2021-22

Quarterly Reports

Q1 - Unaudited Finanical Results 30-06-2021
Q2 - Un-audited Financial Results 30-09-2021
Q3 - Unaudited Financial Results 31-12-2021
Q4 - Audited Financial Results 31-03-2022

Annual Report

Annual Report 2020-21
Dr. Agarwal's - Scrutinizer Report for the 27th AGM
MGT-7 Annual Return - 2020-21
Proceeding of the 27th Annual General Meeting
Book Closure Intimation

Quarterly Reports

Q1 - Unaudited-Financial-Results-30-06-2020
Q2 - Unaudited-Financial-Results-30-09-2020
Q3 - Unaudited-Financial-Results-31-12-2020
Q4 - Audited Financial Results - 31-03-2021

Annual Report

Annual Report 2019-20
26th AGM Consolidated Scrutinizers Report
Book closure Intimation
Proceeding of the 26th Annual General Meeting

Quarterly Reports

Q1 - Unaudited financial results for the quarter ended 30th June 2019
Q2 - Unaudited financial results for the quarter ended 30th September 2019
Q3 - Unaudited financial results for the quarter ended 31st December 2019
Q4 - Audited financial results for the quarter ended 31st March 2020

Annual Report

Annual Report 2018-19
25th AGM- Combined Scrutinizer Report
Proceedings of AGM

Quarterly Reports

Q1 - Unaudited financial results for the quarter ended 30th June 2018
Q2 - Unaudited financial results for the quarter ended 30th September 2018
Q3 - Unaudited financial results for the quarter ened 31st December 2018
Q4 - Audited financial results for the quarter ened 30th April 2019

Annual Report

Annual Report 2017-18
24th AGM- Combined Scrutinizer Report
AGM - Summary of Proceedings

Quarterly Reports

Q1 - April-2017-June-2017-
Q2 - July-2017-September-2017
Q3 - October-2017-December-2017-
Q4 - January-2018-March-2018

Annual Report

Annual Report 2016-17
23rd AGM- Combined Scrutinizer Report
Intimaiton of Book Closure - AGM
Proceedings of AGM

Quarterly Reports

Q1 - Unaudited financial results for the quarter ended 30th June 2016
Q2 - Unaudited financial results for the quarter ended 30th September 2016
Q3 - Unaudited financial results for the quarter ended 31st December 2016
Q4 - Audited financal results for the quarter ended 31st March 2017

Annual Report

Annual Report 2015-16
22nd AGM- Combined Scrutinizer Report
Proceedings of AGM

Quarterly Reports

Q1 - Unaudited financial results for the quarter ended 30th June 2015
Q2 - Unaudited financial results for the quarter ended 30th September 2015
Q3 - Unaudited financial results for the quarter ended 31st December 2015
Q4 - Audited financial results for the quarter ended 31st March 2016

Get In Touch